Intra-Cellular Therapies (NASDAQ: ITCI) announced that it is assuming sponsorship of the Investigational New Drug Application (IND) for studies related ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE